The way professional tennis conceals its negative effects on players has a certain quality. The rankings, match statistics, and highlight reels don’t convey what goes on behind the scenes when a body begins to indicate that something is amiss. Early in 2026, Emma Navarro discovered this the hard way when her underactive thyroid subtly destroyed months of work and prevented her from participating in a tour that she had just recently mastered.
Navarro had gotten up fast. She was ranked eighth in the world by 2024 thanks to a combination of above-average fitness, a workmanlike consistency that felt almost stubborn in the best way, and baseline relentlessness. Thus, it didn’t take long for the internet commentary to surface when she started to appear different—heavier, slower, and obviously exhausted. The quiet was broken by social media, as it usually does. A portion of it was worry. Much of it was simply cruel.

Credit: Tennis Channel
Hypothyroidism was the final diagnosis, which was made public during Wimbledon coverage. It is brought on by an underactive thyroid gland and affects touring professional athletes in exactly the way you would expect: it slows metabolism, depletes energy, and results in unintended weight gain unrelated to discipline or diet. It is simple to overlook early symptoms. They eventually become unavoidable. The tour itself probably made Navarro’s condition worse because thyroid levels do not quietly stabilize in situations involving frequent travel, accumulated stress, and the physical demands of professional tennis.
She was not present at the Miami WTA 1000. Her home event, Charleston, was missed. For someone who had spent years developing toward the top of the game, taking nearly three months off the tour is not insignificant. Given the subtle changes in her movement and service motion that were apparent even before her absence, it’s possible that she saw the writing on the wall earlier than she’s stated in public. It’s difficult to tell from the outside if those were early symptoms or a coincidence.
She returned with a title. By most accounts, her victory at the WTA 500 Strasbourg in May was the biggest accomplishment of her career to date. The context surrounding the draw was more important than the draw’s historical depth. It takes a level of focus that most people never have to acquire to win anything after a two-month medical leave while continuing to manage a chronic illness that calls for constant observation and medication.
Speaking in Paris before the French Open, Navarro said that the tour “exacerbates” underlying problems. That’s a methodical way of saying it. Outsiders truly underestimate how relentless the WTA schedule is. The matches aren’t the only thing. It’s the flights, time zones, hotel accommodations, and the ongoing adjustment of routine, food, and sleep. It is truly challenging for an athlete to manage hypothyroidism, a chronic illness that necessitates careful blood monitoring and medication adjustments.
It’s important to state unequivocally that Navarro’s weight gain was a medical symptom rather than a lifestyle decision. The comment sections mostly failed to make this important distinction. It’s common to interpret an athlete’s physical changes as a sign of diminished commitment or lack of motivation. In Navarro’s instance, it was the reverse. She was still trying to compete, but her body was working against her.
The condition of hypothyroidism does not go away on its own. It is controlled, not cured, by medication, observation, and understanding what the illness requires each week. By all accounts, Navarro has embraced that leadership style. Instead of competing in spite of it, the Strasbourg title implied that she is managing to do so. For anyone who has managed a chronic illness while attempting to lead a demanding career, that is a significant distinction.
As her story develops, it seems that neither the diagnosis nor the weight are the most significant factors. It’s because she was patient. It would have been easier for her rankings, sponsor obligations, and public perception if she had stayed on the hamster wheel, as her team put it, but she chose to step off of it. In retrospect, that quiet, largely unexplained decision appears better than it likely felt at the time.
